Sort
51,593 grants matching “hepatitis”
Defining the therapeutic efficacy, tolerogenic potential, and genotoxicity of liver-targeted AAV gene therapy for hemophilia A
$707,639Graca Duarte Almeida-Porada · Wake Forest University Health Sciences · R01 · FY2022 · HL
The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission
$707,588Eric Orman · Indiana University Indianapolis · R01 · FY2023 · DK
Probing the specificity and activity of the metazoan Integrator complex
$707,558Karen L Adelman · Harvard Medical School · R01 · FY2024 · GM
CVD in American Indians Biomarker lab and Arizona Field Center
$707,555Barbara V Howard · Medstar Health Research Institute · R01 · FY2015 · HL
Adiponectin and CTRP9 signaling in muscle and liver
$707,419Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2012 · DK
Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes
$707,389Tatyana Kushner · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
Impact and Utilization of Scalable Functional Assays in Alagille Syndrome
$707,330Melissa Ann Gilbert · Children'S Hosp Of Philadelphia · R01 · FY2025 · DK
Role of Tim Family Genes in Asthma and Allergic Diseases
$707,268Stanford University · P01 · FY2003 · AI
Plant-derived vaccines against hepatitis C Cooperative *
$707,140Charles Joel Arntzen · Arizona State University-Tempe Campus · U19 · FY2007 · AI
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections
$707,109Shashi Kapadia · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DA
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use
$707,105Shenghan Lai · Johns Hopkins University · R01 · FY2013 · DA
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$707,087Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2023 · DK
A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment among Young Adult People who Inject Drugs
$707,087Meghan D Morris · University Of California, San Francisco · R01 · FY2023 · DA
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
$707,036T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$707,036T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases
$707,036T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
KLF14 and Atherosclerosis
$706,887Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
KLF14 and Atherosclerosis
$706,887Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning
$706,875Janice E. Chambers · Mississippi State University · U01 · FY2021 · NS
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$706,868Christopher L King · Case Western Reserve University · R01 · FY2023 · AI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
$706,804Donna K. Arnett · University Of Kentucky · R01 · FY2017 · HL
HCV Disease Management in HIV-HCV Coinfected IDUs
$706,777Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2017 · DA
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$706,742Christopher L King · Case Western Reserve University · R01 · FY2022 · AI
Determinants of AAV Tropism
$706,729Aravind Asokan · Duke University · R01 · FY2025 · HL
Inflammatory response to sleep apnea in obese subjects
$706,674Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2009 · HL